oncology
GU Cancer

Local and international expert opinions on KEYNOTE-045 in advanced urothelial carcinoma

Sponsored by MSD

Watch Dr Krieger and Professor Bellmunt provide commentary and insights on the KEYNOTE-045 study, in patients with locally advanced and metastatic urothelial cancer post progression on platinum-containing chemotherapy, and the relevance to patients in Australia. In this 3 chapter video series Sydney-based medical oncologist Dr Laurence Krieger and lead author of the KEYNOTE-045 study, Professor ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic